Disease Mechanism of Action Note
Disease Mechanism of Action Note
Disease Mechanism of Action Note
Arrythmias CVR33
Tachyarrhythmia=HR greater than
conventional number of 100 beats/min
If this occurs for more than 5 consecutive
beats it is
tachycardia=sustained when it lasts for
more than 30 seconds
Paroxysmal tachy: when it starts and stops
abruptly
Incessant tachy: when it occurs most of
the time
**Classic, Ventricular vs Supra-Ventricular
(e.g. by WPW syndrome)
**Electropysiology, wide vs narrow QRS
DRUGS/TRE
ATMENT
Class Ia:
Disopyramid
e, Quinidine,
Procainamide
MECHANISM OF ACTION
NOTE
Class Ib:
Lignocaine,
Mexiletine
SE:
*Quinidine: administered orally, GI side effects.
Cinchonism CNS S/E tinnitus, hearing loss,
visual disturbances, confusion and psychosis.
Antibody induced thrombocytopenia
*Disopyramide: Anticholinergic effects: Nausea,
vomiting, dry mouth, urinary retention
* Procainamide: Given PO, IV or IM. Associated
with N+V, Rash, Arthralgia
-Lupus like syndrome occurs more frequently
and earlier in patients who are slow acetylators of
procainamide
Main SE and given IV is CNS toxicity
Mech of DZ:
Usually associated with structural
abnormality of myocardium
Ischaemia
Heart failure
Hypertrophic Obstructive
Cardiomyopathy
Premature beats: cause of irregular
response
Atrial fibrillation: most common type
Class Ic:
Propafenone,
Flecainide
Flecanide:
SE Proarrythmic, given by
Electrophysiologist
Propafenone:
SE: Exacerbation of lung disease due to partial
beta blocking action
Given orally
Class II: Beta
blockers
(propranolol,
atenolol )
Class III:
Amiodarone,
Bretylium,
Sotalol
Class IV:
Calcium
Channel
Blockers
Long QT syndrome
*Inherited arrhythmogenic disease
characterised by life threatening
ventricular arrhythmia
*Autosomal Dominant; Romano-Ward
Recessive assoc with deafness; Jervell
Lange-Nielsen
Brugada Syndrome
Autosomal Dominant Inherited
Structurally normal heart
ST segment elevation in right heart
leads
Susceptible to ventricular tachycardia